Compounds > methylprednisolone

methylprednisolone and Scleroderma, Systemic

methylprednisolone has been researched along with Scleroderma, Systemic in 54 studies

Research

Studies (54)

TimeframeStudies, this research(%)All Research%
pre-19907 (12.96)18.7374
1990's5 (9.26)18.2507
2000's22 (40.74)29.6817
2010's14 (25.93)24.3611
2020's6 (11.11)2.80

Authors

AuthorsStudies
Azuma, Y; Furusawa, A; Hasegawa, S; Korenaga, Y; Okazaki, F; Wakiguchi, H; Yasudo, H1
Enghelmayer, JI; García-Moyano, M; Gaser, A; González-Echavarri, C; Malfante, P; Martín-Iglesias, D; Moreno-Torres, V; Ruiz-Irastorza, G; Vivero, F1
Baharani, A; Reddy P, RR1
Camprodon-Gómez, M; Fernández-Codina, A; Pope, JE1
Bag-Ozbek, A; Elghawy, AA; Oh, KS; Pociurko, B; Skopis, M1
Ali, AM; Elawamy, A; Hassanien, M; Kamel, EZ; Roushdy, ASI; Talaat, EA1
Fransen, J; Kersten, BE; Knaapen-Hans, HKA; Thurlings, RM; van den Hombergh, WMT; van den Hoogen, FHJ; van der Kraan, PM; Vonk, MC1
Hamada-Ode, K; Horino, T; Ichii, O; Terada, Y1
Cox, A; Heaton, V; Munro, J; Renton, WD; Samuel, C; Soh, HJ1
Andrews, T; Becker, ML; Dedeoglu, F; Feldman, BM; Ferguson, PJ; Fuhlbrigge, RC; Higgins, GC; Hong, S; Ibarra, MF; Laxer, RM; Li, SC; Mason, T; Pope, E; Punaro, M; Rabinovich, CE; Stewart, K; Torok, KS1
Conforti, ML; De Marchi, D; Gargani, L; Guiducci, S; Lombardi, M; Matucci-Cerinic, M; Moggi-Pignone, A; Picano, E; Pingitore, A; Randone, SB1
Goh, KG; Ong, SG1
Abignano, G; Bissell, LA; Buch, MH; Del Galdo, F; Emery, P1
Fujita, T; Hori, Y; Matsukawa, T; Mimura, I; Tojo, A; Uozaki, H1
Hayashi, H; Hayashihara, K; Iizuka, T; Kawabata, Y; Kokuho, N; Masuko, H; Matsuyama, M; Morimoto, K; Oota, K; Saito, T1
Almodovar, R; Carmona, L; Carreira, PE; Joven, BE1
Depresseux, G; Houssiau, FA; Vanthuyne, M1
Bloch, DB; Deshpande, V; Khosroshahi, A; Stone, JH1
Alberici, E; Bergamaschi, R; Caporali, R; Ceroni, M; Franciotta, D; Marchioni, E; Piccolo, G; Piccolo, L; Romani, A; Zardini, E1
Choi, YJ; Kim, HO; Kim, HS; Lee, JY; Park, YM1
Baszis, K; Becker, M; Campillo, S; Cartwright, V; Cidon, M; Dedeoglu, F; Ferguson, PJ; Fuhlbrigge, RC; Higgins, GC; Hong, S; Ilowite, NT; Inman, CJ; Jacobe, HT; Jerath, R; Lasky, A; Laxer, RM; Li, SC; O'Neil, KM; Pope, E; Rabinovich, CE; Torok, KS; Vora, S; Wallace, CA; Zeft, A1
Nishibu, A; Oyama, N; Sakai, E; Yamamoto, T1
Emery, P; Griffiths, B; Miles, S; Moss, H; Robertson, R; Veale, D1
Hara, M; Kamatani, N; Kotake, S; Nanke, Y1
Akizuki, S; Hattori, Y; Katsumata, Y; Kuwana, M; Matsuoka, Y; Sugiura, H; Suzuki, T1
SILTZBACH, LE1
Aihara, Y; Ikezawa, Y; Imagawa, T; Iwata, N; Katakura, S; Kondo, M; Miyamae, T; Mori, M; Sasaki, T; Yokota, S1
Cetkovská, P; Pizinger, K; Skálová, A1
Alekperov, RT; Avdeev, SN; Kotovskaia, MA1
Kawai, S1
Idutsu, K; Minami, R; Miyamura, T; Suematsu, E; Yamamoto, M1
Aguilar, JL; Avalos-Díaz, E; González, I; Herrera-Esparza, R; López-Robles, E; Saucedo, A1
Ikeda, T; Imai, K; Motoya, S; Sone, A; Sugaya, T; Suzuki, J; Taga, M; Takahashi, H; Tsukuda, H; Yasui, H1
Hara, M; Kamatani, N; Koizumi, K; Okamoto, H; Suzuki, Y; Tateishi, M1
Andonopoulos, AP; Antonopoulos, I; Kalliolias, G; Katsiberis, G; Liossis, SN; Pastromas, V; Yiannopoulos, G1
Bacciu, A; Fantini, F; Galbiati, V; Ingegnoli, F; Zeni, S1
D'Agostino, L; D'Angelo, S; Olivieri, I; Palazzi, C; Petricca, A1
Hatanaka, M; Namba, T; Takahara, K; Takahashi, A; Takeji, M; Uzu, T; Yamauchi, A1
Krause, W1
Hammerschmied, W; Holubar, K; Konrad, K1
Battisti, E; Fattorini, L; Fioravanti, A; Giordano, N; Magaro, L; Marcolongo, R; Marcucci, P1
Ishioka, S; Yamakido, M; Yamana, S; Yamanishi, Y1
Hosono, S; Kato, K; Murakami, R; Muramatsu, M; Omote, A; Sano, H; Sugimoto, Y; Tanaka, H; Watanabe, Y1
Krajnc, I1
Geniaux, M; Labbe, L; Sibaud, V; Toussaint, P1
Fujisawa, M; Fukami, K; Iida, S; Katayama, T; Kato, S; Kohno, K; Majima, K; Morimatsu, M; Nishida, H; Okuda, S; Sata, M; Ueda, S1
Asano, S; Fukaya, S; Hasegawa, M; Ishii, K; Katayama, M; Kato, K; Kawashima, S; Komatsu, Y; Matsumura, H; Miyama, H; Mizutani, A; Nagai, T; Oshima, H; Tanaka, I; Torikai, K; Yoshida, S1
Czirják, L; Komócsi, A; Kumánovics, G; Zibotics, H1
Davies, G; Gough, A; Johnson, AH; Lorenzi, AR1
Hara, I; Miyake, H1
Nassonova, VA1
Jimenez, SA; Neilson, EG; Ntoso, KA; Tomaszewski, JE1
Carette, S; Mathon, G; Turcotte, J1
Kornell, S1

Reviews

6 review(s) available for methylprednisolone and Scleroderma, Systemic

ArticleYear
Pyoderma gangrenosum associated with limited cutaneous systemic sclerosis: a rare case with literature review.
    Clinical rheumatology, 2021, Volume: 40, Issue:3

    Topics: Arthritis, Rheumatoid; Humans; Inflammatory Bowel Diseases; Methylprednisolone; Pyoderma Gangrenosum; Scleroderma, Systemic

2021
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Rheumatology international, 2019, Volume: 39, Issue:5

    Topics: Antirheumatic Agents; Biological Products; Biopsy; Child, Preschool; Contracture; Edema; Hematopoietic Stem Cell Transplantation; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Methylprednisolone; Mycophenolic Acid; Prednisolone; Protein Kinase Inhibitors; Scleroderma, Localized; Scleroderma, Systemic; Skin; Synovitis; Treatment Failure; Treatment Outcome

2019
[Nephropathies in patients with collagen diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6

    Topics: Combined Modality Therapy; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Renal Dialysis; Scleroderma, Systemic; Vasculitis

2004
[Efficacy of anti-thymocyte globulin and cyclosporin A combined therapy in aplastic anemia complicated with limited cutaneous systemic sclerosis].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2005, Volume: 28, Issue:2

    Topics: Aged; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Methylprednisolone; Penicillamine; Pulse Therapy, Drug; Scleroderma, Systemic

2005
Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.
    Annals of the rheumatic diseases, 2001, Volume: 60, Issue:8

    Topics: Aged; Anemia, Iron-Deficiency; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gastric Antral Vascular Ectasia; Humans; Immunosuppressive Agents; Methylprednisolone; Pulse Therapy, Drug; Scleroderma, Systemic; Sclerotherapy; Treatment Outcome

2001
[A case of progressive systemic sclerosis complicated by crescentic glomerulonephritis and diffuse pulmonary hemorrhage].
    Nihon Jinzo Gakkai shi, 1992, Volume: 34, Issue:7

    Topics: Adult; Glomerulonephritis; Hemorrhage; Humans; Kidney; Lung Diseases; Male; Methylprednisolone; Scleroderma, Systemic

1992

Trials

4 trial(s) available for methylprednisolone and Scleroderma, Systemic

ArticleYear
Intra-Carpal Injection of Ozone versus Methylprednisolone in Carpal Tunnel Syndrome of Systemic Sclerosis Patients: A Randomized Single-Blind Clinical Trial.
    Pain physician, 2021, Volume: 24, Issue:4

    Topics: Carpal Tunnel Syndrome; Humans; Methylprednisolone; Neural Conduction; Ozone; Scleroderma, Systemic; Single-Blind Method; Treatment Outcome

2021
Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial.
    Trials, 2018, Aug-22, Volume: 19, Issue:1

    Topics: Administration, Intravenous; Anti-Inflammatory Agents; Biomarkers; Capillaries; Clinical Protocols; Double-Blind Method; Early Diagnosis; Glucocorticoids; Humans; Inflammation Mediators; Methylprednisolone; Microscopic Angioscopy; Nails; Netherlands; Predictive Value of Tests; Research Design; Scleroderma, Systemic; Time Factors; Treatment Outcome

2018
Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
    The Journal of rheumatology, 2002, Volume: 29, Issue:11

    Topics: Adult; Aged; Anti-Inflammatory Agents; Clinical Protocols; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lung; Lung Diseases, Interstitial; Lung Volume Measurements; Male; Methylprednisolone; Middle Aged; Pilot Projects; Respiratory Physiological Phenomena; Scleroderma, Systemic; Tomography, X-Ray Computed

2002
Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.
    Rheumatology international, 2007, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Respiratory Function Tests; Scleroderma, Systemic; Tomography, X-Ray Computed; Treatment Outcome

2007

Other Studies

44 other study(ies) available for methylprednisolone and Scleroderma, Systemic

ArticleYear
Successful treatment of children with juvenile systemic sclerosis using mycophenolate mofetil after methylprednisolone pulse therapy: A 3-year follow-up.
    International journal of rheumatic diseases, 2022, Volume: 25, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Mycophenolic Acid; Scleroderma, Localized; Scleroderma, Systemic; Treatment Outcome

2022
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
    Seminars in arthritis and rheumatism, 2023, Volume: 59

    Topics: Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Myositis; Prednisone; Scleroderma, Systemic; Treatment Outcome

2023
Bilateral Retinopathy and Optic Neuropathy Associated with Systemic Sclerosis.
    Ocular immunology and inflammation, 2020, Jul-03, Volume: 28, Issue:5

    Topics: Adult; Color Vision Defects; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infusions, Intravenous; Methylprednisolone; Optic Nerve Diseases; Papilledema; Retinal Diseases; Retinal Pigment Epithelium; Retrospective Studies; Scleroderma, Systemic; Scotoma

2020
Giant Calcinosis in Dermatomyositis and Scleroderma Overlap.
    Arthritis & rheumatology (Hoboken, N.J.), 2020, Volume: 72, Issue:7

    Topics: Calcinosis; Cyclosporine; Dermatomyositis; Drainage; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Muscle Weakness; Raynaud Disease; Scleroderma, Systemic; Skin Diseases; Subcutaneous Tissue; Symptom Flare Up; Thoracic Wall; Tomography, X-Ray Computed

2020
Overlapping Syndrome of Systemic Scleroderma and Cryoglobulinemic Vasculitis.
    The American journal of medicine, 2019, Volume: 132, Issue:6

    Topics: Cryoglobulinemia; Female; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Prednisolone; Scleroderma, Systemic; Vasculitis

2019
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Pediatric rheumatology online journal, 2019, Jul-15, Volume: 17, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antirheumatic Agents; Child; Comparative Effectiveness Research; Drug Therapy, Combination; Feasibility Studies; Female; Glucocorticoids; Humans; Male; Methotrexate; Methylprednisolone; Pilot Projects; Prednisone; Prospective Studies; Rare Diseases; Scleroderma, Localized; Scleroderma, Systemic; Young Adult

2019
Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:10

    Topics: Adult; Early Diagnosis; Edema, Cardiac; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Pulmonary Edema; Scleroderma, Systemic

2013
Recurrent spontaneous subdural hematoma secondary to immune thrombocytopenia in a patient with overlap syndrome.
    Lupus, 2015, Volume: 24, Issue:1

    Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Female; Hematoma, Subdural; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Platelet Count; Radiography; Recurrence; Scleroderma, Systemic; Thrombocytopenia; Young Adult

2015
Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
    Rheumatology (Oxford, England), 2016, Volume: 55, Issue:12

    Topics: Cyclophosphamide; Disease Management; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Scleroderma, Systemic

2016
Noncrescentic ANCA-associated renal crisis in systemic sclerosis.
    Clinical nephrology, 2008, Volume: 70, Issue:2

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Diagnosis, Differential; Female; Glomerulonephritis; Glucocorticoids; Humans; Methylprednisolone; Prednisolone; Scleroderma, Systemic

2008
[Case of systemic sclerosis sine scleroderma showing pulmonary venula lesion that suggests pulmonary veno-occlusive disease].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:5

    Topics: Aged; Female; Humans; Hypertension, Pulmonary; Methylprednisolone; Prednisolone; Pulmonary Veno-Occlusive Disease; Pulse Therapy, Drug; Scleroderma, Systemic; Treatment Outcome

2009
Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Seminars in arthritis and rheumatism, 2010, Volume: 39, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Antirheumatic Agents; Cause of Death; Cyclophosphamide; Female; Glucocorticoids; Humans; Hypertension, Pulmonary; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Risk Factors; Scleroderma, Systemic; Spain; Survival Rate; Treatment Outcome

2010
Safety of intravenous methylprednisolone therapy in patients suffering from systemic sclerosis.
    Scandinavian journal of rheumatology, 2010, Volume: 39, Issue:2

    Topics: Acute Kidney Injury; Adult; Blood Pressure; Female; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Scleroderma, Systemic

2010
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.
    Arthritis and rheumatism, 2010, Volume: 62, Issue:6

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Autoantibodies; Autoimmune Diseases; Combined Modality Therapy; Drug Administration Schedule; Female; Glucocorticoids; Humans; Immunoglobulin G; Male; Methylprednisolone; Middle Aged; Rituximab; Scleroderma, Systemic; Severity of Illness Index; Treatment Outcome

2010
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis.
    Journal of the neurological sciences, 2011, Apr-15, Volume: 303, Issue:1-2

    Topics: Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Brain; Facial Nerve Diseases; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Muscle Weakness; Myelitis, Transverse; Neuromyelitis Optica; Prednisolone; Scleroderma, Systemic; Spinal Cord

2011
Case of juvenile localized scleroderma with joint sclerosis and Sjögren's syndrome in a child with precocious puberty.
    The Journal of dermatology, 2011, Volume: 38, Issue:10

    Topics: Child; Female; Humans; Joint Diseases; Methotrexate; Methylprednisolone; Puberty, Precocious; Scleroderma, Localized; Scleroderma, Systemic; Sclerosis; Sjogren's Syndrome; Triptorelin Pamoate

2011
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
    Arthritis care & research, 2012, Volume: 64, Issue:8

    Topics: Adolescent; Consensus; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Methylprednisolone; Practice Guidelines as Topic; Program Development; Randomized Controlled Trials as Topic; Scleroderma, Localized; Scleroderma, Systemic; Treatment Outcome; Young Adult

2012
Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
    The Australasian journal of dermatology, 2012, Volume: 53, Issue:2

    Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Bosentan; Humans; Hypertension, Pulmonary; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Sulfonamides

2012
[Isolated pulmonary hypertension in overlap syndrome: successful treatment by methylprednisolone pulse therapy].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2003, Volume: 26, Issue:1

    Topics: Adult; Female; Humans; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Methylprednisolone; Pulse Therapy, Drug; Scleroderma, Systemic; Syndrome

2003
Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:6

    Topics: Autoantibodies; Bone Marrow Cells; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Injections, Intravenous; Megakaryocytes; Methylprednisolone; Middle Aged; Neoplasm Proteins; Proto-Oncogene Proteins; Pulse Therapy, Drug; Purpura, Thrombocytopenic, Idiopathic; Receptors, Cytokine; Receptors, Thrombopoietin; Remission Induction; Scleroderma, Systemic

2003
DIFFUSE PULMONARY GRANULOMATOSES AND FIBROSES.
    Modern treatment, 1964, Volume: 1

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Beryllium; Chloroquine; Dexamethasone; Eosinophilic Granuloma; Granulomatosis with Polyangiitis; Humans; Lung Diseases; Methylprednisolone; Pharmacology; Pneumoconiosis; Prednisolone; Prednisone; Pulmonary Fibrosis; Radiation Injuries; Sarcoidosis; Scleroderma, Systemic; Silicosis; Therapeutics; Toxicology; Triamcinolone

1964
[Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Ryumachi. [Rheumatism], 2003, Volume: 43, Issue:4

    Topics: Adolescent; Child; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Pulse Therapy, Drug; Scleroderma, Systemic; Treatment Outcome

2003
Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease.
    Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:6

    Topics: Bone Marrow Transplantation; Cyclosporine; Epidermolysis Bullosa Acquisita; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Penicillamine; Scleroderma, Systemic

2003
[Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma].
    Terapevticheskii arkhiv, 2004, Volume: 76, Issue:3

    Topics: Adult; Beclomethasone; Bronchiolitis Obliterans; Cyclophosphamide; Female; Humans; Methylprednisolone; Penicillamine; Scleroderma, Systemic; Treatment Outcome

2004
Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:5

    Topics: Antibodies, Antineutrophil Cytoplasmic; Biopsy, Needle; CREST Syndrome; Cyclophosphamide; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Methylprednisolone; Middle Aged; Peroxidase; Risk Assessment; Scleroderma, Systemic; Severity of Illness Index; Treatment Outcome

2005
[Case of protein-losing gastroenteropathy associated with scleroderma in which central serous chorioretinopathy developed].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2001, Volume: 24, Issue:3

    Topics: Adult; Chorioretinitis; Female; Humans; Methylprednisolone; Prednisolone; Protein-Losing Enteropathies; Pulse Therapy, Drug; Scleroderma, Systemic; Treatment Outcome

2001
A case of severe acute pancreatitis, in overlap syndrome of systemic sclerosis and systemic lupus erythematosus, successfully treated with plasmapheresis.
    Modern rheumatology, 2006, Volume: 16, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Female; Gabexate; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Pancreatitis; Plasmapheresis; Prednisone; Scleroderma, Systemic; Serine Proteinase Inhibitors; Syndrome

2006
Bilateral vocal fold immobility in a patient with overlap syndrome rheumatoid arthritis/systemic sclerosis.
    Clinical rheumatology, 2007, Volume: 26, Issue:10

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Connective Tissue Diseases; Cyclophosphamide; Dyspnea; Female; Fibrosis; Humans; Methylprednisolone; Scleroderma, Systemic; Treatment Outcome; Vocal Cords; Voice Disorders

2007
Acute myositis in a patient with systemic sclerosis after the administration of darbepoetin alpha.
    Rheumatology international, 2008, Volume: 28, Issue:3

    Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Darbepoetin alfa; Dose-Response Relationship, Drug; Erythropoietin; Female; Hematinics; Humans; Injections, Subcutaneous; Methylprednisolone; Middle Aged; Myositis; Prednisone; Scleroderma, Systemic; Severity of Illness Index; Treatment Outcome

2008
[Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Nihon Jinzo Gakkai shi, 2008, Volume: 50, Issue:1

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Biomarkers; Disease Progression; Glomerular Basement Membrane; Glomerulonephritis; Humans; Immunoglobulin G; Male; Methylprednisolone; Peroxidase; Prednisolone; Pulse Therapy, Drug; Renal Dialysis; Scleroderma, Systemic

2008
[Endocrine changes in gestagen treatment in a patient with scleroderma diffusa].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1980, Volume: 31, Issue:1

    Topics: Adult; Androstenedione; Dehydroepiandrosterone; Estradiol; Humans; Male; Methylprednisolone; Pituitary Hormones, Anterior; Progesterone; Progesterone Congeners; Scleroderma, Systemic; Testosterone

1980
[Temporal arteritis in systemic scleroderma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1982, Volume: 33, Issue:3

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Methylprednisolone; Scleroderma, Systemic; Skin; Temporal Arteries

1982
Systemic sclerosis following anti-androgenic treatment for prostatic adenocarcinoma.
    Clinical rheumatology, 1993, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Cyproterone Acetate; Humans; Male; Methylprednisolone; Middle Aged; Orchiectomy; Prostatic Neoplasms; Scleroderma, Systemic

1993
Development of ischemic colitis and scleroderma renal crisis following methylprednisolone pulse therapy for progressive systemic sclerosis.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:7

    Topics: Acute Kidney Injury; Colitis; Fatal Outcome; Female; Humans; Ischemia; Methylprednisolone; Middle Aged; Scleroderma, Systemic

1996
Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:7

    Topics: Acute Kidney Injury; Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Autoimmune Diseases; Biopsy, Needle; Combined Modality Therapy; Dipyridamole; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Neutrophils; Peroxidase; Plasmapheresis; Prednisolone; Ribonucleosides; Scleroderma, Systemic

1997
[Arndt-Gottron scleromyxedema. Summary of 2 years treatment].
    Wiener klinische Wochenschrift, 1997, Dec-23, Volume: 109, Issue:24

    Topics: Cyclosporine; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Scleroderma, Systemic; Skin

1997
[POEMS syndrome revealed by a scleroderma-like skin thickening].
    Annales de dermatologie et de venereologie, 2000, Volume: 127, Issue:1

    Topics: Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Female; Humans; Methylprednisolone; Middle Aged; Plasmapheresis; POEMS Syndrome; Scleroderma, Systemic; Selective Estrogen Receptor Modulators; Skin; Tamoxifen

2000
A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment.
    Clinical nephrology, 2000, Volume: 53, Issue:6

    Topics: Aged; Anemia, Hemolytic; Blood Pressure; Glucocorticoids; Humans; Kidney; Lung Diseases, Interstitial; Male; Methylprednisolone; Renal Insufficiency; Scleroderma, Systemic

2000
[A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
    Ryumachi. [Rheumatism], 2000, Volume: 40, Issue:5

    Topics: Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Female; Glomerulonephritis; Humans; Methylprednisolone; Middle Aged; Peroxidase; Pulse Therapy, Drug; Scleroderma, Systemic; Treatment Outcome

2000
Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis.
    Rheumatology international, 2001, Volume: 20, Issue:3

    Topics: Adult; Aged; Azathioprine; Bronchoalveolar Lavage Fluid; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphocyte Count; Methylprednisolone; Middle Aged; Neutrophils; Pulmonary Fibrosis; Respiratory Function Tests; Scleroderma, Systemic

2001
Current developments in rheumatology in the Soviet Union.
    Arthritis and rheumatism, 1988, Volume: 31, Issue:1

    Topics: Ambulatory Care; Cyclophosphamide; Dimethyl Sulfoxide; Disease Susceptibility; HLA Antigens; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Microcirculation; Rheumatic Diseases; Rheumatology; Scleroderma, Systemic; USSR

1988
Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1986, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Biopsy; Female; Glomerulonephritis; Humans; Kidney Glomerulus; Lupus Erythematosus, Systemic; Methylprednisolone; Penicillamine; Scleroderma, Systemic

1986
Severe myositis and myocarditis in progressive systemic sclerosis.
    The Journal of rheumatology, 1985, Volume: 12, Issue:5

    Topics: Adult; Echocardiography; Female; Humans; Methylprednisolone; Myocarditis; Myositis; Scleroderma, Systemic

1985
Adverse effect of corticosteroid therapy in a patient with progressive systemic sclerosis (generalized scleroderma).
    Manitoba medical review, 1966, Volume: 46, Issue:9

    Topics: Adult; Cardiomyopathies; Humans; Male; Methylprednisolone; Scleroderma, Systemic

1966